Balasan surat pertanyaan pertama dalam proses pemeriksaan IPO di STAR Market untuk Zhongke Kehua Kechuang

LightningPacketLoss · 2026-03-30T13:09:25+00:00

Perusahaan Jiangsu Zhongke Kehua New Materials Co., Ltd. telah merespons surat pertanyaan dalam tahap awal peninjauan IPO di STAR Market, dengan rencana mengumpulkan sekitar 598 juta yuan untuk pengembangan bahan kemasan semikonduktor dan modal kerja. Perusahaan fokus pada bahan epoksi plastik kemasan, menghadapi tantangan dalam persaingan produk dan teknologi inti.

LightningPacketLoss

2026-03-30 13:09:25

Pembuatan abstrak sedang berlangsung

Beijing Business Daily News (Reporter Ma Huanhuan Li Jiaxue) On the evening of March 25, the SSE website showed that Jiangsu Zhongke Keke New Materials Co., Ltd. (hereinafter “Zhongke Keke”) disclosed the responses to the first round of inquiry letters for its Science and Technology Innovation Board IPO to the public.

It is reported that Zhongke Keke is a national-level specialized, sophisticated, and innovative “little giant” enterprise focusing on the R&D, production, and sales of semiconductor packaging materials. Its main products are epoxy molding compounds. The company’s IPO received acceptance on December 5, 2025, and entered the inquiry stage on December 24 of the same year.

In its attempt to go public, Zhongke Keke plans to raise approximately 598 million yuan. After deducting issuance expenses, the net proceeds will be used for the R&D and industrialization projects for mid-to-high-end epoxy molding compounds for semiconductor packaging, as well as to supplement working capital.

In the first round of the inquiry letter, Zhongke Keke’s products and market competition, core technologies, shareholders, and other matters were put under further questioning.

Lihat Asli

Halaman ini mungkin berisi konten pihak ketiga, yang disediakan untuk tujuan informasi saja (bukan pernyataan/jaminan) dan tidak boleh dianggap sebagai dukungan terhadap pandangannya oleh Gate, atau sebagai nasihat keuangan atau profesional. Lihat Penafian untuk detailnya.